Clinical Trials Sponsored by Materna Medical

Total 56365 results

AEterna Zentaris

Completed

Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency

Growth Hormone Deficiency With Pituitary Anomalies

United Kingdom, United States, France, Poland, Spain, Austria, Germany, Italy, Serbia
AEterna Zentaris

Completed

Perifosine + Sunitinib Malate for Patients With Advanced Cancers

Renal Cancer | GIST
AEterna Zentaris

Completed

AE-941 in Treating Patients With Metastatic Kidney Cancer

Kidney Cancer

Canada
AEterna Zentaris

Completed

Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma

Multiple Myeloma

United States
AEterna Zentaris

Completed

Cetrorelix Pamoate in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)

Benign Prostatic Hypertrophy

Netherlands, Belarus, Bulgaria, Czech Republic, France, Germany, Italy, Macedonia, The Former Yugoslav Republic of, Romania, United Kingdom
Boston Medical Center
HRSA/Maternal and Child Health Bureau

Completed

Supporting the Well Being of Families of Young Children With Autism Spectrum Disorders

Maternal Depression

United States
Nanjing Medical University
HRSA/Maternal and Child Health Bureau

Completed

Doula Combined Latent Phrase Epidural Analgesia in Primiparous Women (DCLEAP)

Labor Pain

China
Nanjing Medical University
HRSA/Maternal and Child Health Bureau

Completed

Influence of Propofol on Alveolar Macrophage in Asthmatic Patients (PAMAP)

Asthma

China
Nanjing Medical University
HRSA/Maternal and Child Health Bureau

Completed

Intravenous Remifentanil for Labor Analgesia (IRELAN)

Labor Pain

China
Nanjing Medical University
HRSA/Maternal and Child Health Bureau

Completed

Comparison of Butorphanol and Tramadol Associated Patient-Controlled Analgesia (PCA) After Hysterectomy (BATPCAH)

Postoperative Pain | Hysterectomy

China
Nanjing Medical University
HRSA/Maternal and Child Health Bureau

Completed

Epidural Analgesia in Different Cervix Diameter and the Rate of Cesarean Delivery (EACDRCD)

Labor Pain

China
Nanjing Medical University
HRSA/Maternal and Child Health Bureau

Completed

Fluid Management for Cesarean Section (FMCS)

Cesarean Section

China
AEterna Zentaris

Completed

Phase II Study of Perifosine in Patients With Refractory and Relapsed Leukemia

Leukemia
AEterna Zentaris

Completed

A Food Effect and QTc Study of Perifosine in Patients With Advanced Malignancies

Cancer

United States
AEterna Zentaris

Completed

Trial of Two Schedules of Perifosine for Patients With Solid Tumors or Lymphomas

Tumors | Lymphomas
AEterna Zentaris

Completed

Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple Myeloma

Multiple Myeloma

United States
AEterna Zentaris

Completed

Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma Patients

Multiple Myeloma | Multiple Myeloma in Relapse
AEterna Zentaris

Terminated

Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer

Breast Cancer

United States, Germany
AEterna Zentaris

Completed

Phase I Trial of Docetaxel With Perifosine

Neoplasms

United States
AEterna Zentaris

Completed

Phase I Perifosine and Gemcitabine Study

Neoplasms

United States
AEterna Zentaris

Completed

Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer (X-PECT)

Colorectal Cancer

United States
AEterna Zentaris

Completed

Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH) (AEZS-102-Z041)

Benign Prostatic Hypertrophy

United States, Canada
AEterna Zentaris

Completed

Investigation of a New, Oral Growth Hormone Secretagogue, AEZS-130 as a Growth Hormone Stimulation Test.

Diagnosis of Adult Growth Hormone Deficiency (AGDH)

United States
AEterna Zentaris

Completed

Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer (ZoptEC)

Endometrial Cancer

United States, Spain, Canada, Ireland, Norway, Austria, Denmark, Israel, United Kingdom, Belgium, Finland, Romania, Czechia, Italy, Poland, Germany, Netherlands, Belarus, Bosnia and Herzegovina, Bulgaria, Russian Federation, Ukraine
AEterna Zentaris

Completed

Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma

Non Small Cell Lung Cancer | Metastatic Breast Cancer | Solid Tumors | Sarcomas
AEterna Zentaris

Completed

Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients

Colon Cancer

United States
AEterna Zentaris

Completed

A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer

United States
AEterna Zentaris

Completed

Ph II Study of Perifosine for Patients With Carcinoma of the Kidney

Kidney Cancer

United States
AEterna Zentaris

Completed

Phase I Study of Perifosine + Sorafenib for Patients With Advanced Cancers

Renal Cancer | Tumors
AEterna Zentaris

Completed

Phase I Trial of Paclitaxel With Perifosine

Neoplasms

United States
AEterna Zentaris

Completed

AE-941 in Treating Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

Canada
Center For Maternal Fetal Medicine

Completed

Amniotic Fluid Sludge in Cerclage Patients as an Indicator for Increased Risk of Preterm Delivery and Neonatal Outcome.

High Risk Pregnancy | Incompetent Cervix | Cerclage | Amniotic Fluid Sludge | Gestation Age at Delivery.

United States
Natera, Inc.

Not yet recruiting

A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial Biopsy (ACES-EMB)

Heart Transplant Failure and Rejection
Natera, Inc.

Recruiting

Study for the Prediction of Active Rejection in Organs Using Donor-derived Cell-free DNA Detection (SPARO)

Complications | Transplant Rejection | Allograft Rejection

United States
Natera, Inc.

Active, not recruiting

Prospera Test Evaluation in Cardiac Transplant (ProTECT) (ProTECT)

Heart Transplant Rejection

United States
Natera, Inc.

Completed

Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies (VANISH)

Trisomy 21 | Trisomy 18 | Trisomy 13 | Vanishing Twin

United States
Natera, Inc.

Completed

Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA (Microdel Triad)

Trisomy 21 | Trisomy 18 | Trisomy 13 | Sex Chromosome Abnormalities | Microdeletion Syndromes

United States
Mateon Therapeutics

Unknown

Dose Escalation of OXi4503 as Single Agent and Combination With Cytarabine w/Subsequent Ph 2 Cohorts for AML and MDS (AML)

Myelodysplastic Syndromes | Acute Myelogenous Leukemia

United States
Mateon Therapeutics

Completed

A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers (GI-NETorPNET)

Neuroendocrine Tumors

United States
Mateon Therapeutics

Terminated

Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer (FACT)

Anaplastic Thyroid Cancer

United States, India, Belarus, Bulgaria, Egypt, Israel, Italy, Poland, Romania, Russian Federation, Ukraine, United Kingdom
Natera, Inc.

Completed

Collection of Maternal Blood Samples for Development of Non-invasive Prenatal Diagnostic Testing

Pregnancy Following IVF With PGS/PGD

United States
Mateon Therapeutics

Completed

Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid Tumors

Tumors

United Kingdom
Anhui Medical University
Ma'anshan Maternal and Child Health Care Hospital

Active, not recruiting

The Ma'Anshan Birth Cohort (MABC)

Birth Defects | Child Development | Pregnancy Outcome | Environmental Exposure | Maternal and Child Health | Health Problems in Pregnancy

China
Nanjing Medical University
Confidential Enquiry into Maternal and Child Health

Completed

Effect of Psychological Interventions on Maternal Outcomes Undergoing Cesarean (PIMAC)

Perioperative Psychology

China
Nanjing Medical University
Confidential Enquiry into Maternal and Child Health

Completed

Nurses' Negative Words and Postoperative Pain Management (NWPOP)

Postoperative Pain

China
Hospital Materno-Infantil de Málaga

Completed

Effect of Synthetic Oxytocin Administered During Labor on Breastfeedings

Breastfeeding
Azienda Sanitaria Locale di Matera

Completed

Vertistop® D and Vertistop® L in Preventing Recurrence of High-recurrence BPPV

Benign Paroxysmal Positional Vertigo (BPPV)

Italy
Natera, Inc.

Recruiting

Clinical Utility of the Addition of a SNP-based NIPT Zygosity Determination in Twin Pregnancy Management. (ZTWINS)

Pregnancy Complications | Twin to Twin Transfusion Syndrome | Multiple Gestation; Maternal Care

United States
Natera, Inc.

Active, not recruiting

LAMBDA 002 (Lung Registry) Study

Lung Transplant Rejection

United States
Natera, Inc.

Active, not recruiting

Renasight Clinical Application, Review and Evaluation (RenaCARE) Study (RenaCARE)

Kidney Diseases

United States

Clinical Trials Sponsored by Materna Medical

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations